Invivyd (IVVD) Share-based Compensation (QoQ) (2021 - 2025)
Invivyd (IVVD) Share-based Compensation (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Invivyd | 105.60 Mn | -121.09 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -79.81% |
| Sep 30, 2025 | 299.37% |
| Jun 30, 2025 | -83.26% |
| Mar 31, 2025 | 521.52% |
| Dec 31, 2024 | 6.66% |
| Sep 30, 2024 | -66.24% |
| Jun 30, 2024 | 57.82% |
| Mar 31, 2024 | 23.83% |
| Dec 31, 2023 | 1.88% |
| Sep 30, 2023 | -8.83% |
| Jun 30, 2023 | -13.39% |
| Mar 31, 2023 | -72.89% |
| Dec 31, 2022 | 169.23% |
| Sep 30, 2022 | 16.32% |
| Jun 30, 2022 | 268.11% |
| Mar 31, 2022 | 117.44% |
| Dec 31, 2021 | -265.71% |
| Sep 30, 2021 | 78.90% |
| Jun 30, 2021 | 469.34% |
| Mar 31, 2021 | 487.00% |